Literature DB >> 21613615

Coordinate regulation of GATA-3 and Th2 cytokine gene expression by the RNA-binding protein HuR.

Cristiana Stellato1, Matthew M Gubin, Joseph D Magee, Xi Fang, Jinshui Fan, Danielle M Tartar, Jing Chen, Garrett M Dahm, Robert Calaluce, Francesca Mori, Glenn A Jackson, Vincenzo Casolaro, Craig L Franklin, Ulus Atasoy.   

Abstract

The posttranscriptional mechanisms whereby RNA-binding proteins (RBPs) regulate T cell differentiation remain unclear. RBPs can coordinately regulate the expression of functionally related genes via binding to shared regulatory sequences, such as the adenylate-uridylate-rich elements (AREs) present in the 3' untranslated region (UTR) of mRNA. The RBP HuR posttranscriptionally regulates IL-4, IL-13, and other Th2 cell-restricted transcripts. We hypothesized that the ARE-bearing GATA-3 gene, a critical regulator of Th2 polarization, is under HuR control as part of its coordinate posttranscriptional regulation of the Th2 program. We report that in parallel with stimulus-induced increase in GATA-3 mRNA and protein levels, GATA-3 mRNA half-life is increased after restimulation in the human T cell line Jurkat, in human memory and Th2 cells, and in murine Th2-skewed cells. We demonstrate by immunoprecipitation of ribonucleoprotein complexes that HuR associates with the GATA-3 endogenous transcript in human T cells and found, using biotin pulldown assay, that HuR specifically interacts with its 3'UTR. Using both loss-of-function and gain-of-function approaches in vitro and in animal models, we show that HuR is a critical mediator of stimulus-induced increase in GATA-3 mRNA and protein expression and that it positively influences GATA-3 mRNA turnover, in parallel with selective promotion of Th2 cytokine overexpression. These results suggest that HuR-driven posttranscriptional control plays a significant role in T cell development and effector function in both murine and human systems. A better understanding of HuR-mediated control of Th2 polarization may have utility in altering allergic airway inflammation in human asthmatic patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21613615      PMCID: PMC5801757          DOI: 10.4049/jimmunol.1001881

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  58 in total

1.  Ribonomics: identifying mRNA subsets in mRNP complexes using antibodies to RNA-binding proteins and genomic arrays.

Authors:  Scott A Tenenbaum; Patrick J Lager; Craig C Carson; Jack D Keene
Journal:  Methods       Date:  2002-02       Impact factor: 3.608

2.  Genome-wide analysis of mRNA decay in resting and activated primary human T lymphocytes.

Authors:  Arvind Raghavan; Rachel L Ogilvie; Cavan Reilly; Michelle L Abelson; Shalini Raghavan; Jayprakash Vasdewani; Mitchell Krathwohl; Paul R Bohjanen
Journal:  Nucleic Acids Res       Date:  2002-12-15       Impact factor: 16.971

Review 3.  The AU-rich transcriptome: more than interferons and cytokines, and its role in disease.

Authors:  Khalid S A Khabar
Journal:  J Interferon Cytokine Res       Date:  2005-01       Impact factor: 2.607

4.  Altered IL-4 mRNA stability correlates with Th1 and Th2 bias and susceptibility to hypersensitivity pneumonitis in two inbred strains of mice.

Authors:  Noah S Butler; Martha M Monick; Timur O Yarovinsky; Linda S Powers; Gary W Hunninghake
Journal:  J Immunol       Date:  2002-10-01       Impact factor: 5.422

5.  Posttranscriptional regulation of IL-13 in T cells: role of the RNA-binding protein HuR.

Authors:  Vincenzo Casolaro; Xi Fang; Brian Tancowny; Jinshui Fan; Fan Wu; Subramanya Srikantan; S Yukiko Asaki; Umberto De Fanis; Shau-Ku Huang; Myriam Gorospe; Ulus X Atasoy; Cristiana Stellato
Journal:  J Allergy Clin Immunol       Date:  2008-02-14       Impact factor: 10.793

6.  Two distinct destabilizing elements in the c-fos message trigger deadenylation as a first step in rapid mRNA decay.

Authors:  A B Shyu; J G Belasco; M E Greenberg
Journal:  Genes Dev       Date:  1991-02       Impact factor: 11.361

7.  Real time quantitative PCR.

Authors:  C A Heid; J Stevens; K J Livak; P M Williams
Journal:  Genome Res       Date:  1996-10       Impact factor: 9.043

8.  Interleukin-13 upregulates eotaxin expression in airway epithelial cells by a STAT6-dependent mechanism.

Authors:  S Matsukura; C Stellato; S N Georas; V Casolaro; J R Plitt; K Miura; S Kurosawa; U Schindler; R P Schleimer
Journal:  Am J Respir Cell Mol Biol       Date:  2001-06       Impact factor: 6.914

9.  A lineage-specific transcriptional silencer regulates CD4 gene expression during T lymphocyte development.

Authors:  S Sawada; J D Scarborough; N Killeen; D R Littman
Journal:  Cell       Date:  1994-06-17       Impact factor: 41.582

10.  Parallel and independent regulation of interleukin-3 mRNA turnover by phosphatidylinositol 3-kinase and p38 mitogen-activated protein kinase.

Authors:  X F Ming; G Stoecklin; M Lu; R Looser; C Moroni
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

View more
  26 in total

1.  GATA-3 augmentation down-regulates Connexin43 in Helicobacter pylori associated gastric carcinogenesis.

Authors:  Xiaoming Liu; Ke Cao; Canxia Xu; Tingzi Hu; Li Zhou; Dan Cao; Jing Xiao; Ling Luo; Yinjie Guo; Yong Qi
Journal:  Cancer Biol Ther       Date:  2015-04-22       Impact factor: 4.742

2.  IL-33 dysregulates regulatory T cells and impairs established immunologic tolerance in the lungs.

Authors:  Chien-Chang Chen; Takao Kobayashi; Koji Iijima; Fan-Chi Hsu; Hirohito Kita
Journal:  J Allergy Clin Immunol       Date:  2017-02-11       Impact factor: 10.793

3.  RNA-Binding Protein HuR Promotes Th17 Cell Differentiation and Can Be Targeted to Reduce Autoimmune Neuroinflammation.

Authors:  Jing Chen; Jennifer L Martindale; Kotb Abdelmohsen; Gaurav Kumar; Paolo M Fortina; Myriam Gorospe; Abdolmohamad Rostami; Shiguang Yu
Journal:  J Immunol       Date:  2020-03-13       Impact factor: 5.422

4.  Transcriptional Profiling of Th2 Cells Identifies Pathogenic Features Associated with Asthma.

Authors:  Grégory Seumois; Jose Zapardiel-Gonzalo; Brandie White; Divya Singh; Veronique Schulten; Myles Dillon; Denize Hinz; David H Broide; Alessandro Sette; Bjoern Peters; Pandurangan Vijayanand
Journal:  J Immunol       Date:  2016-06-06       Impact factor: 5.422

5.  Regulation of CUG-binding protein 1 (CUGBP1) binding to target transcripts upon T cell activation.

Authors:  Daniel Beisang; Bernd Rattenbacher; Irina A Vlasova-St Louis; Paul R Bohjanen
Journal:  J Biol Chem       Date:  2011-11-23       Impact factor: 5.157

Review 6.  Post-transcriptional regulation of inflammation by RNA-binding proteins via cis-elements of mRNAs.

Authors:  Yutaro Uchida; Tomoki Chiba; Ryota Kurimoto; Hiroshi Asahara
Journal:  J Biochem       Date:  2019-11-01       Impact factor: 3.387

7.  HuR controls apoptosis and activation response without effects on cytokine 3' UTRs.

Authors:  Fedor V Karginov
Journal:  RNA Biol       Date:  2019-03-04       Impact factor: 4.652

8.  The RNA-binding protein HuR contributes to neuroinflammation by promoting C-C chemokine receptor 6 (CCR6) expression on Th17 cells.

Authors:  Jing Chen; Jennifer L Martindale; Carole Cramer; Myriam Gorospe; Ulus Atasoy; Paul D Drew; Shiguang Yu
Journal:  J Biol Chem       Date:  2017-07-06       Impact factor: 5.157

9.  Outcome-Related Signatures Identified by Whole Transcriptome Sequencing of Resectable Stage III/IV Melanoma Evaluated after Starting Hu14.18-IL2.

Authors:  Richard K Yang; Igor B Kuznetsov; Javed Khan; Paul M Sondel; Erik A Ranheim; Jun S Wei; Sivasish Sindiri; Berkley E Gryder; Vineela Gangalapudi; Young K Song; Viharkumar Patel; Jacquelyn A Hank; Cindy Zuleger; Amy K Erbe; Zachary S Morris; Renae Quale; KyungMann Kim; Mark R Albertini
Journal:  Clin Cancer Res       Date:  2020-03-09       Impact factor: 12.531

10.  Conditional knockout of the RNA-binding protein HuR in CD4⁺ T cells reveals a gene dosage effect on cytokine production.

Authors:  Matthew M Gubin; Patsharaporn Techasintana; Joseph D Magee; Garrett M Dahm; Robert Calaluce; Jennifer L Martindale; Maryln S Whitney; Craig L Franklin; Cindy Besch-Williford; John W Hollingsworth; Kotb Abdelmohsen; Myriam Gorospe; Ulus Atasoy
Journal:  Mol Med       Date:  2014-03-20       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.